Opexa Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2635 Technology Forest Blvd, The Woodlan...Phone Number
(281) 272-9331Website
www.opexatherapeutics.comRevenue
<$5 MillionStock Symbol
OPXAIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Opexa Therapeutics
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The companys lead product candidate is Tcelna, a T-cell immunotherapy for the treatment of patients with secondary progressive MS. It is also developing OPX-212, an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is headquartered in The Woodlands,...Explore more
Opexa Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Opexa Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Opexa Therapeutics had a recent Job posting/layoffs
Check if Opexa Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Opexa Therapeutics
Earning: See what the market has to say on Opexa Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Opexa Therapeutics has new funding data
Opexa Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Opexa Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Opexa Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Opexa Therapeutics
Find more new buyers
Compare Similar Companies to Opexa Therapeutics
Compare insights from companies similar to Opexa Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Opexa Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Opexa Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Opexa Therapeutics.
Opexa Therapeutics financials insights
Gather financial insights about Opexa Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$18M
Opexa Therapeutics Tech Stack
A closer look at the technologies used by Opexa Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Opexa Therapeutics
Sign Up For FreeTo access detailed company insights
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The companys lead product candidate is Tcelna, a T-cell immunotherapy for the treatment of patients with secondary progressive MS. It is also developing... Read More
